Iveric Bio to Report Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
July 28 2021 - 8:00AM
Business Wire
IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will
report its second quarter 2021 financial and operating results on
Wednesday, August 4, 2021. Following the announcement, the Iveric
Bio management team will host a live conference call and webcast at
8:00 a.m. Eastern Time to discuss the Company’s financial results
and provide a general business update.
To participate in this conference call, dial 1-888-317-6003
(USA) or 1-412-317-6061 (International), passcode 7257034. A live,
listen-only audio webcast of the conference call can be accessed on
the Investors section of the Iveric Bio website at
www.ivericbio.com. A replay will be available approximately two
hours following the live call for two weeks. The replay number is
1-877-344-7529 (USA Toll Free), passcode 10158843.
About Iveric Bio
Iveric Bio is a science-driven biopharmaceutical company focused
on the discovery and development of novel treatment options for
retinal diseases with significant unmet medical needs. The Company
is currently developing both therapeutic product candidates for
age-related retinal diseases and gene therapy product candidates
for orphan inherited retinal diseases. For more information on the
Company, please visit www.ivericbio.com.
Forward-looking Statements
Any statements in this press release about Iveric Bio’s future
expectations, plans and prospects constitute forward-looking
statements for purposes of the safe harbor provisions under the
Private Securities Litigation Reform Act of 1995. Actual results
may differ materially from those indicated by such forward-looking
statements as a result of various important factors. Any
forward-looking statements represent Iveric Bio’s views only as of
the date of this press release. Iveric Bio anticipates that
subsequent events and developments will cause its views to change.
While Iveric Bio may elect to update these forward-looking
statements at some point in the future, Iveric Bio specifically
disclaims any obligation to do so.
ISEE-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210728005035/en/
Investor Contact: Iveric Bio Kathy Galante, 212-845-8231
Senior Vice President, Investor Relations
kathy.galante@ivericbio.com
or
Media Contact: SmithSolve Alex Van Rees, 973-442-1555
ext. 111 alex.vanrees@smithsolve.com
IVERIC bio (NASDAQ:ISEE)
Historical Stock Chart
From Mar 2024 to Apr 2024
IVERIC bio (NASDAQ:ISEE)
Historical Stock Chart
From Apr 2023 to Apr 2024